Treatment of maxillary hemangioma with a sclerosing agent.
This article reports the case of a patient with a reasonably large maxillary hemangioma involving bone and overlying mucosa. A dramatic shrinkage of the lesion over a 4-week period was noted when sodium morrhuate was used as the sclerosing agent. Four and one half years following therapy, no recurrence of the tumor was noted. Radiographically, the area of involvement had become significantly more dense, with an increase in size and calcification of phleboliths in the area.
D000328:Adult; D005227:Fatty Acids / Q000627:therapeutic use*; D006391:Hemangioma / Q000473:pathology / Q000628:therapy*; D006801:Humans; D008297:Male; D008441:Maxillary Neoplasms / Q000473:pathology / Q000628:therapy*; D012597:Sclerosing Solutions / Q000627:therapeutic use; D012976:Sodium Morrhuate / Q000627:therapeutic use*
D005227:Fatty Acids; D012597:Sclerosing Solutions; D012976:Sodium Morrhuate